title: [Efficacy of transesophageal pacing for correction of newly diagnosed atrial fibrillation of type I in patients with coronary heart disease].
abstract: OBJECTIVE
  To analyse the results of using transesophageal pacing (TEP) for correction of atrial fibrillation of type I (AF).
  
  
  METHODS
  The study included 1283 patients with coronary heart disease (CHD) and newly diagnosed AF. All the patients were examined with transthoracic echocardiography, received basic antianginal treatment. AF was corrected with TEP.
  
  
  RESULTS
  Sinus rhythm was reestablished in 83.48% patients, in 67.33% TEP was made without previous antiarrhythmic therapy, in the rest patients with this pretreatment. The best result was observed in pre-pacing administration of amiodaron or its combination with hinidin-durules. Only 2.88% patients retained AF after TEP.
  
  
  CONCLUSIONS
  TEP is an effective method of type I AF treatment.
authors.forename: A I
authors.initials: AI
authors.lastname: Olesin
authors.forename: Z Iu
authors.initials: ZIu
authors.lastname: Smolin
authors.forename: O A
authors.initials: OA
authors.lastname: Konovalova
authors.forename: A V
authors.initials: AV
authors.lastname: Shabrov
mesh_terms: D000328:Adult; D000368:Aged; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D003327:Coronary Disease / Q000150:complications*; D004562:Electrocardiography; D022062:Electrophysiologic Techniques, Cardiac; D006801:Humans; D008875:Middle Aged; D010138:Pacemaker, Artificial
chemical_list: D000889:Anti-Arrhythmia Agents; D000638:Amiodarone